Juan De La Garza, EMT-Basic with Lifeline, received the COVID-19 vaccine Saturday, Dec. 19, 2020, at the UTRGV School of Medicine’s Medical Education Building on the Edinburg Campus. (UTRGV Photo by Paul Chouy)
A Mercedes Fire Department first responder gets the COVID-19 vaccine Saturday, Dec. 19, 2020, at the UTRGV School of Medicine, at the UTRGV School of Medicine’s Medical Education Building on the Edinburg Campus. (UTRGV Photo by Paul Chouy)
The UTRGV School of Medicine on Dec. 19, 2020, administered the COVID-19 vaccine to area EMS providers, like these from McAllen, at the UTRGV School of Medicine’s Medical Education Building on the Edinburg Campus. (UTRGV Photo by Paul Chouy)
Esteban Gonzalez, a lieutenant with the Pharr Fire Department, received the COVID-19 vaccine Saturday, Dec. 19, 2020, at the UTRGV School of Medicine’s Medical Education Building on the Edinburg Campus. (UTRGV Photo by Paul Chouy)
Mega Doctor News
- Advertisement -
By News and Internal Communications
RIO GRANDE VALLEY, TEXAS –– UT Health RGV on Saturday continued to strengthen frontline personnel by administering the COVID-19 vaccine to EMS providers from across the Rio Grande Valley who engage in 9-1-1 emergency services like pre-hospital care and transport.
Saturday’s inoculations were part of UT Health RGV’s continued efforts for Phase 1A vaccination distribution as determined by the Centers for Disease Control and Prevention and the Texas Department of State Health Services.
- Advertisement -
“UTRGV and UT Health RGV are committed to serving the Valley community, as federal and state distribution guidelines expand,” said Dr. John H. Krouse, UTRGV executive vice president for Health Affairs and dean of the UTRGV School of Medicine.
Super Bowl parties often feature takeout, delivery and foods that are served over several hours. To help prevent foodborne illness, the U.S. Department of Agriculture’s (USDA) Food Safety and Inspection Service (FSIS) is reminding fans to keep food safety in play on game day.
A team of scientists at the Centro Nacional de Investigaciones Oncológicas (CNIO) has reported the complete elimination of pancreatic tumors in mice using a combination of three targeted drugs.
The Centers for Disease Control and Prevention (CDC) today announced that its Traveler-Based Genomic Surveillance (TGS) program has surpassed one million voluntary participants, marking a significant milestone in the United States' ability to detect and respond to emerging public health threats at our borders.